{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:01Z","timestamp":1791357241664,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Program on Key Basic Research Project","award":["2015CB553504"],"award-info":[{"award-number":["2015CB553504"]}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.schres.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T10:21:03Z","timestamp":1484648463000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis"],"prefix":"10.1016","volume":"185","author":[{"given":"Zhihua","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.01.002_bb0005","first-page":"71","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr. Bull","volume":"36","author":"Buchanan","year":"2010"},{"key":"10.1016\/j.schres.2017.01.002_bb0010","first-page":"1817","article-title":"Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials","volume":"11","author":"Cai","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2017.01.002_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/wps.20128","article-title":"Risks of all-cause and suicide mortality in mental disorders: a meta-review","volume":"13","author":"Chesney","year":"2014","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2017.01.002_bb0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1192\/bjp.171.6.586b","article-title":"Tardive dyskinesia in CYP2D6 polymorphism in Chinese","volume":"171","author":"Chong","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.002_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1440-1819.2004.01194.x","article-title":"Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change","volume":"58","author":"Chong","year":"2004","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2017.01.002_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2007.03.003","article-title":"Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study","volume":"93","author":"Davidson","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.01.002_bb0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability","volume":"26","author":"DeLeon","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.schres.2017.01.002_bb0040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat. Med."},{"key":"10.1016\/j.schres.2017.01.002_bb0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s007020170044","article-title":"Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients","volume":"108","author":"Garcia-Barcelo","year":"2001","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"10.1016\/j.schres.2017.01.002_bb0050","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"Ivan Os","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2017.01.002_bb0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2006.09.012","article-title":"Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial","volume":"90","author":"Kane","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.01.002_bb0060","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2017.01.002_bb0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/sj.mp.4001485","article-title":"Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic\/Scottish risk haplotype","volume":"9","author":"Li","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.002_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.biopsych.2010.06.014","article-title":"Common variants in major histocompatibility complex region and TCF4 gene are significantly associated with schizophrenia in Han Chinese","volume":"68","author":"Li","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.002_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0004867414536931","article-title":"Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China","volume":"49","author":"Li","year":"2015","journal-title":"Aust. N Z J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.002_bb0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/CEOR.S44325","article-title":"The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy","volume":"5","author":"Montgomery","year":"2013","journal-title":"Clinicoecon. Outcomes Res."},{"key":"10.1016\/j.schres.2017.01.002_bb0085","doi-asserted-by":"crossref","unstructured":"Oh, G. H., Yu, J. C., Choi, K. S., Joo, E. J. & Jeong, S. H., 2015. Simultaneous comparison of efficacy and tolerability of second-generation antipsychotics in schizophrenia: mixed-treatment comparison analysis based on head-to-head trial data. Psychiatry Investig. 12, 46\u201354.","DOI":"10.4306\/pi.2015.12.1.46"},{"key":"10.1016\/j.schres.2017.01.002_bb0090","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(09)60660-7","article-title":"Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001\u201305: an epidemiological survey","volume":"373","author":"Phillips","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2017.01.002_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","article-title":"Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons","volume":"38","author":"Rummel-Kluge","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.01.002_bb0100","doi-asserted-by":"crossref","unstructured":"Samara, M. T., Dold, M., Gianatsi, M., Nikolakopoulou, A., Helfer, B., Salanti, G. & Leucht, S., 2016. Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry 73, 199\u2013210.","DOI":"10.1001\/jamapsychiatry.2015.2955"},{"key":"10.1016\/j.schres.2017.01.002_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1745-6215-10-46","article-title":"Randomized trials published in some Chinese journals: how many are randomized?","volume":"10","author":"Wu","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.schres.2017.01.002_bb0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5414\/CP201505","article-title":"Tardive dyskinesia in the treatment of schizophrenia: the findings of the Research on Asian Psychotropic Prescription Pattern (REAP) survey (2001\u20132009)","volume":"49","author":"Xiang","year":"2011","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.schres.2017.01.002_bb0115","first-page":"841","article-title":"Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review","volume":"10","author":"Xue","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2017.01.002_bb0120","first-page":"349","article-title":"Effectiveness, tolerability and safety of flexible-dose treatment with oral extended release paliperidone in acute schizophrenia","volume":"22","author":"Yu","year":"2010","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.002_bb0125","first-page":"153","article-title":"The efficacy and safety of flexible doses of paliperidone extended-release tablets in the treatment of acute schizophrenia: a randomized, double blind olanzapine-controlled study","volume":"42","author":"Zhang","year":"2009","journal-title":"Clin. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.002_bb0130","first-page":"113","article-title":"Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review","volume":"12","author":"Zhang","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417300014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417300014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T13:15:20Z","timestamp":1568726120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417300014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":26,"alternative-id":["S0920996417300014"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.002","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}